Streetbeat News

BUD

Anheuser-Busch InBev SA/NV

Industry

Beverages - Alcoholic

Anheuser-Busch InBev SA/NV engages in the production, distribution, and sale of beer, alcoholic beverages, and soft drinks worldwide. It offers a portfolio of approximately 500 beer brands, which primarily include Budweiser, Corona, and Stella Artois; Beck's, Hoegaarden, Leffe, and Michelob Ultra; and Aguila, Antarctica, Bud Light, Brahma, Cass, Castle, Castle Lite, Cristal, Harbin, Jupiler, Modelo Especial, Quilmes, Victoria, Sedrin, and Skol brands. The company was founded in 1366 and is headquartered in Leuven, Belgium.

Open

61.96

Mkt cap

121B

Volume

2.7M

High

62.42

P/E Ratio

21.80

52-wk high

67.49

Low

61.77

Div yield

0.01

52-wk low

45.94

Chamath Palihapitiya, a billionaire investor, announced the creation of an incubator named 8090, which aims to use AI and offshoring to develop enterprise software at a significant discount. He suggested that this could disrupt the software market by reducing the need for businesses to pay subscription fees to software providers. Mark Cuban responded to Palihapitiya's announcement with a cautionary note about tax implications related to R&D with foreign developers, referencing Sec 174. The article also mentions past public disagreements between Palihapitiya and Cuban, including debates over political ideologies affecting business and consumer behavior.

Portfolio Pulse from Chris Katje

January 15, 2024 | 2:38 pm

Constellation Brands (NYSE:STZ) reported Q3 financials below expectations due to high inflation affecting demand for its high-priced spirits. Sales were $2.47 billion, missing estimates of $2.54 billion. Organic net sales for premium wines and spirits dropped 7%, with an expected annual drop of 7-9%. Beer sales grew 4%, benefiting from smaller pack sizes and competitor Anheuser-Busch InBev's (NYSE:BUD) social media backlash. Boston Beer (NYSE:SAM) reported flat revenues but is innovating with new flavors. Constellation faces challenges with high packaging costs, competition, and operating expenses but maintains its fiscal 2024 profit forecast.

Portfolio Pulse from Upwallstreet

January 12, 2024 | 2:57 pm

Exane BNP Paribas analyst Gen Cross has downgraded Anheuser-Busch InBev (NYSE:BUD) from Outperform to Neutral.

Portfolio Pulse from Benzinga Newsdesk

January 12, 2024 | 10:56 am

Wall Street analysts have updated their price targets and ratings for several companies. Jefferies upgraded Anheuser-Busch (BUD) and raised its target. Telsey Advisory increased Urban Outfitters' (URBN) target, maintaining an Outperform rating. Goldman Sachs downgraded Etsy (ETSY) and cut its target. Mizuho raised EQT Corporation's (EQT) target, maintaining a Buy rating. Needham increased ACM Research's (ACMR) target, maintaining a Buy rating. RBC Capital upgraded Duke Energy (DUK) and raised its target. JP Morgan upgraded Raymond James Financial (RJF) and increased its target. Citigroup downgraded Charles Schwab (SCHW) and cut its target. Raymond James raised Lululemon's (LULU) target, maintaining an Outperform rating. Goldman Sachs downgraded Mercury Systems (MRCY) and cut its target.

Portfolio Pulse from Avi Kapoor

January 10, 2024 | 12:53 pm

Jefferies analyst Edward Mundy upgraded Anheuser-Busch InBev (NYSE:BUD) from Hold to Buy and increased the price target from $60 to $76.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 9:50 am

Constellation Brands Inc (NYSE:STZ) reported Q3 earnings with a rise in net income to $509.1 million but cut its full-year EPS guidance due to a sales forecast miss and challenges in the wine market. Modelo Especial's growth was a highlight, while the wine and spirits segment saw a decline in sales and shipments. STZ shares rose 2.79% to $249.08 at the time of reporting.

Portfolio Pulse from Patricio Liddle

January 05, 2024 | 5:39 pm

As the New Year begins, investors may consider the impact of resolutions on fitness and health-related stocks. Planet Fitness (PLNT) saw a 0.7% increase, while Anheuser-Busch Inbev (BUD) fell 0.5% on the first trading day of 2024. Historical data shows mixed results for stocks like W.W. International (WW) and Peloton (PTON), with no clear trend correlating New Year resolutions to sustained stock performance. Pharmaceutical companies like Novo Nordisk (NVO) and Eli Lilly (LLY) have seen significant gains due to their weight loss drugs, with shares up 50.7% and 60.7% respectively in 2023.

Portfolio Pulse from Neil Dennis

January 02, 2024 | 5:58 pm

Analysts have upgraded Spotify Technology (SPOT), Anheuser-Busch Inbev SA (BUD), and Restaurant Brands International Inc. (QSR) despite concerns of a potential recession in 2024. Spotify's strong financials and workforce reduction are expected to drive profitability, with Pivotal Research and Rosenblatt Securities setting price targets of $265 and $300, respectively. Anheuser-Busch is recovering from a sales decline due to a controversy, with JPMorgan setting a price target of $79. Restaurant Brands is expected to see increased revenue from holiday sales, with RBC Capital and BMO setting price targets of $87 and $85, respectively.

Portfolio Pulse from Aditi Ganguly

January 01, 2024 | 3:00 pm

Anheuser-Busch InBev's (NYSE:BUD) short interest has decreased by 23.08% since the last report, with 3.46 million shares sold short, representing 0.2% of available shares. The average time to cover these short positions is 2.38 days. A decrease in short interest can indicate a more bullish sentiment towards the stock. BUD's short interest is below its peer group average of 4.80%.

Portfolio Pulse from Benzinga Insights

December 29, 2023 | 3:00 pm

The most-read cannabis stories of 2023 on Benzinga included a range of topics from the benefits of cannabis for aging brains, political shifts towards legalization, and high-profile celebrity endorsements. Key highlights include a study suggesting cannabis does not negatively impact cognition in older adults, Elon Musk's comments on psychoactive drugs, a man ditching morphine for marijuana to alleviate arthritis, Aleafia Health's expansion into Europe's medical cannabis market, a pathogen threatening California's cannabis crops, Florida's telehealth renewals for medical marijuana, GOP senators admitting legalization impacts drug cartels, Tilray's acquisition of beer brands from Anheuser-Busch, Snoop Dogg's anti-Trump TikTok video, Georgia's medical cannabis sales in pharmacies, and Ohio's GOP-led Senate approving expanded marijuana legislation.

Portfolio Pulse from Nina Zdinjak

December 28, 2023 | 2:54 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.